The endothelial monocyte‐activating polypeptide II (EMAP II) is a substrate for caspase‐7
Open Access
- 18 January 2000
- journal article
- Published by Wiley in FEBS Letters
- Vol. 466 (1) , 143-147
- https://doi.org/10.1016/s0014-5793(99)01777-9
Abstract
Endothelial monocyte‐activating polypeptide II (EMAP II) is a proinflammatory cytokine and a chemoattractant for leukocytes. The mature cytokine is formed in apoptotic cells by cleavage of the precursor proEMAP II. Here we show that caspase‐7 is capable of cleaving proEMAP II in vitro. A proEMAP II mutant, in which the ASTD cleavage site was changed to the sequence ASTA, was not processed by caspase‐7. The caspase‐7‐mediated generation and release of mature EMAP II may provide a mechanism for leukocyte recruitment to sites of programmed cell death, and thus may link apoptosis to inflammation.Keywords
This publication has 19 references indexed in Scilit:
- The proteolytic procaspase activation network: an in vitro analysisCell Death & Differentiation, 1999
- Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammationJournal of Clinical Investigation, 1999
- Caspases: their intracellular localization and translocation during apoptosisCell Death & Differentiation, 1999
- Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA SynthetaseJournal of Biological Chemistry, 1999
- Caspase-independent Cell Killing by Fas-associated Protein with Death DomainThe Journal of cell biology, 1998
- Caspase 7‐induced cleavage of kinectin in apoptotic cellsFEBS Letters, 1998
- Proteases to die forGenes & Development, 1998
- Processing and Activation of Pro-Interleukin-16 by Caspase-3Journal of Biological Chemistry, 1998
- Characterization of seven murine caspase family membersFEBS Letters, 1997
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972